Keyphrases
Meropenem
100%
β-lactam Antibiotics
100%
Burkholderia Cepacia
100%
Cystic Fibrosis
100%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
100%
Pseudomonas Aeruginosa (P. aeruginosa)
66%
Forced Expiratory Volume in 1 Second (FEV1)
50%
Minimum Inhibitory Concentration
33%
Geometric Mean
16%
Predictive Value
16%
Aztreonam
16%
Chronic Pulmonary Infections
16%
Treatment Value
16%
Ciprofloxacin
16%
C-reactive Protein
16%
Bacteria-resistant
16%
Rash
16%
Ceftazidime
16%
Imipenem
16%
Antibiotics
16%
Lactams
16%
Pulmonary Function
16%
Nausea
16%
Chronic Infection
16%
Erythrocyte Sedimentation Rate
16%
Intravenous Infusion
16%
Leukocyte Count
16%
Tobramycin
16%
Piperacillin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Burkholderia cepacia
100%
Beta Lactam Antibiotic
100%
Pseudomonas aeruginosa
100%
Meropenem
100%
Infection
33%
Ciprofloxacin
16%
Infectious Agent
16%
Imipenem
16%
Tobramycin
16%
C Reactive Protein
16%
Antibiotics
16%
Nausea
16%
Side Effect
16%
Aztreonam
16%
Ceftazidime
16%
Beta Lactam
16%
Lung Infection
16%
Rash
16%
Piperacillin
16%
Medicine and Dentistry
Cystic Fibrosis
100%
Hypersensitivity
100%
Pseudomonas aeruginosa
100%
Meropenem
100%
Allergic Response
33%
Infection
33%
Pathogen
16%
Lung Function
16%
C Reactive Protein
16%
Patient with Cystic Fibrosis
16%
Leukocyte
16%
Aztreonam
16%
Side Effect
16%
Ceftazidime
16%
Piperacillin
16%
Ciprofloxacin
16%
Exanthem
16%
Erythrocyte Sedimentation Rate
16%
Nausea
16%
Beta Lactam
16%
Tobramycin
16%
Antibiotics
16%
Intravenous Drug Administration
16%
Immunology and Microbiology
Burkholderia cepacia
100%
Hypersensitivity
100%
Pseudomonas aeruginosa
100%
Hypersensitive Response
40%
Minimum Inhibitory Concentration
40%
C-Reactive Protein
20%
Infectious Agent
20%
Lung Function
20%
Leukocyte Count
20%